Directors’ Deals: Barclays’ US chief takes advantage of share price surge
Directors at Barclays are making the most of the share price gains. This month, Denny Nealon, chief executive of Barclays’ US consumer bank, sold more than 100,000 shares for £2.44, or £255,000 in ...
Workday price target raised to $314 from $289 at Barclays
Barclays raised the firm’s price target on Workday (WDAY) to $314 from $289 and keeps an Overweight rating on the shares as part of an ...
Hosted on MSN3d
Barclays Enhances Value with Share Buy-Back
Barclays PLC has repurchased over 1.8 million of its own shares from Citigroup Global Markets Limited, a move that is ...
Barclays: On Track For Super-Charged Shareholder Returns
Barclays stock shows strong upside potential with solid Q3 results, cheap valuation, and promising growth plans. Click here ...
Salesforce price target raised to $415 from $305 at Barclays
Barclays raised the firm’s price target on Salesforce (CRM) to $415 from $305 and keeps an Overweight rating on the shares as part of an ...
The Motley Fool UK22d
Barclays’ share price nears 9-year high after positive Q3 results. What’s the forecast looking ahead?
Barclays came out swinging today with excellent Q3 results. I’m looking to see what it all means for the share price and what kind of returns I can expect. When investing, your capital is at ...
Yahoo Finance25d
Here are the latest share price forecasts for Barclays
Since the start of the year, the Barclays (BARC.L) share price has jumped from £1.55 to £2.42, making the stock one of the FTSE 100’s (^FTSE) best performers of 2024. But what’s next? The ...
Nasdaq21d
Barclays price target raised to 315 GBp from 300 GBp at Morgan Stanley
Morgan Stanley raised the firm’s price target on Barclays (BCS) to 315 GBp from 300 GBp and keeps an Overweight rating on the shares. TipRanks is the most comprehensive data set of sell side ...
Seeking Alpha19d
Barclays: Upgraded Guidance Supports Buy Rating
Whilst loan loss rates remain low, there are signs that Barclays is taking on more credit risk to drive loan growth. The share price has enjoyed a very strong run, but the improved outlook for ...
Business Insider3d
Barclays Keeps Their Buy Rating on AstraZeneca (AZN)
Barclays analyst Emily Field maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of £140.00. The company’s shares closed yesterday at p9,999.00. According ...
Nasdaq23d
Barclays Continues Strategic Share Buy-Back
Barclays (GB:BARC ... The recent transaction, executed at an average price of 239.8315p per share, is part of a broader strategy that has seen the company buy back over 219 million shares ...